Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Application of Intelligent Insulin Dose Calculation Software in Patients With Insulin Therapy：A Randomized Controlled Intervention Trial

NCT05389839 is registered in ClinicalTrials.gov with xiaolong zhao as lead sponsor.

NCT NCT05389839
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05389839 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Application of Intelligent Insulin Dose Calculation Software in Patients With Insulin Therapy：A Randomized Controlled Intervention Trial
Lead sponsor
xiaolong zhao
Phase
Not applicable
Overall status
Unknown status
Start date
October 1, 2021
Completion date
September 30, 2024
Enrollment
182 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

artificial intelligence, insulin therapy, time in range